Physical activity, weight control, and breast cancer risk and survival: Clinical trial rationale and design considerations

Journal of the National Cancer Institute

Volumn 101, Issue 9, 2009, Pages 630-643

  Ballard Barbash, Rachel ^a   Hunsberger, Sally ^a   Alciati, Marianne H ^b   Blair, Steven N ^c   Goodwin, Pamela J ^d   McTiernan, Anne ^e   Wing, Rena ^f   Schatzkin, Arthur ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Susan G Komen for the Cure   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e Fred Hutchinson Cancer Research Center   (United States)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

BEHAVIOR THEORY; BREAST CANCER; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; DIABETES MELLITUS; DIET; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; NOTE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; SAMPLE SIZE; SELF MONITORING; SOCIAL LEARNING THEORY; SYSTEMIC THERAPY; WEIGHT CONTROL; ARTICLE; BIOASSAY; BODY MASS; BODY WEIGHT; BREAST TUMOR; COGNITION; EXERCISE; HEALTH BEHAVIOR; INCIDENCE; METHODOLOGY; MORTALITY; MOTIVATION; MOTOR ACTIVITY; NATIONAL HEALTH ORGANIZATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; UNITED STATES;

BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; COGNITION; ENDPOINT DETERMINATION; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GOALS; HEALTH BEHAVIOR; HUMANS; INCIDENCE; MOTOR ACTIVITY; NATIONAL CANCER INSTITUTE (U.S.); PATIENT SELECTION; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; SAMPLE SIZE; SECONDARY PREVENTION; UNITED STATES;

EID: 65549119535     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp068     Document Type: Note

References (81)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin.2006;56(2):106-130.
2. Byers T, Nestle M, McTiernan A, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin.2002;56(5):92-119.
3. International Agency for Research Cancer. Weight Control and Physical Activity: IARC Working Group on the Evaluation of Cancer- Preventive Agents.Lyon, France: International Agency for Research Cancer; 2002.
4. Kushi LH, Byers T, Doyle C, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin.2006;56(5):254-281.
5. Doyle C, Kushi LH, Byers T, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin.2006;56(5):323-353.
6. Berrigan B, Troiano RP, McNeel T, Disogra C, Ballard-Barbash R. Active Transportation increases Adherence to Activity Recommendations Amer J Prev Med2006;31(3):210-216.
7. Troiano RP, Macera CA, Ballard-Barbash R. Be Physically active each day. How can we Know? J Nutr2001;131:451S-460S.
8. Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc.2008;40(1):181-188.
9. National Center for Health Statistics. NCHS Data on Overweight and Obesity.Centers for Disease Control and Prevention, Hyattsville, Maryland; 2006.
10. The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med.2002;346(6):393-403.
11. Look AHEAD Protocol Review Committee. Look AHEAD (Action for Health in Diabetes): design and methods for a controlled trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Controlled Clin Trials.2003;24(5):610-628.
12. The Writing Group of the Premier Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control. JAMA.2003;289(16):2083-2093.
13. Lee I-M, Oguma Y. Physical activity. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention.3rd ed. New York, NY: Oxford University Press; 2006:449-467.
14. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA.2005;293(20): 2479-2486.
15. Abrahamson PE, Gammon MD, Lund MJ, et al. Recreational physical activity and survival among young women with breast cancer. Cancer.2006;107(8): 1777-1785.
16. Irwin M, Smith AW, McTiernan A, et al. Association of pre- and post- diagnosis physical activity with mortality in breast cancer survivors: the Healthy Eating Activity and Lifestyle (HEAL) Study. J Clin Oncol.2008;26(24):3959-3964.
17. Irwin ML, Ainsworth BE. Physical activity interventions following cancer diagnosis: methodologic challenges to delivery and assessment. Cancer Invest.2004;22(1):30-50.
18. Penedo FJ, Schneiderman N, Dahn J R, Gonzalez JS. Physical activity interventions in the elderly: cancer and comorbidity. Cancer Invest.2004; 22(1):51-67.
19. McTiernan A. Physical activity after cancer: physiologic outcomes. Cancer Invest.2004;22(1):68-81.
20. Schwartz AL. Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest.2004;22(1):82-92.
21. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective.Washington, DC: American Institute for Cancer Research; 2007.
22. Ballard-Barbash R, Friedenreich C, Slattery M, Thune I. Obesity and body composition. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention.3rd ed. New York, NY: Oxford University Press; 2006:422-448.
23. van den Brandt PA, Spieglman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol.2000;152(6):514-527.
24. Lam PH, Vacek PM, Geller BM, Muss HB. The association of increased weight, body mass index, and tissue density with the risk of breast carcinoma in Vermont. Cancer.2000;89(2):369-375.
25. Friedenreich CM, Courneya KS, Bryant HE. Case-control study of anthropometric measures and breast cancer risk. Int J Cancer.2002;99:445- 452.
26. Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA.1997;278:1407-1411.
27. Morimoto LM, White E, Chen Z, et al. Obesity, body size and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control.2002;13:741-751.
28. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund G. A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study. Int J Cancer.2003;103:246-252.
29. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev.2000;9:681-687.
30. Yong LC, Brown CC, Schatzkin A, Schairer C. Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989. Am J Epidemiol.1996; 143(10):985-995.
31. Goodwin P. Energy balance and cancer prognosis, breast cancer. In: McTiernan A, ed. Mechanisms Associating Physical Activity With Cancer Incidence: Exercise and Immune Function.Boca Raton, FL: Taylor & Francis Group, LLC; 2006:405-436.
32. Caan BJ, Kwan ML, Hartzell G, et al. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control.2008;119(10):1319-28.
33. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol.2001;19(9):2381-2389.
34. Irwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol.2005;23(4):774-782.
35. Oguma Y, Sesso RS, Paffenbarger RSJ, Lee I-M. Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med.2002;36(3):162-172.
36. Farrell SW, Braun L, Barlow CE, Cheng YJ, Blair SN. The relation of body mass index, cardiorespiratory fitness, and all-cause mortality in women. Obesity Res.2002;10(6):4 1 7-423.
37. Lee I-M, Rexrode K, Cook NR, Manson JE, Buring JE. Physical activity and coronary heart disease in women: is "no pain, no gain" passé? JAMA.2001;285(11):1447-1454.
38. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA.1995;273(6):461-465.
39. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med.1990;322(13): 882-889.
40. Ashtona WD, Nanchahalb K, Wood DA. Body mass index and metabolic risk factors for coronary heart disease in women. Eur Heart J.2001;22(1):46- 55.
41. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA.2000;283(22):2961-2967.
42. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk: a meta-analysis. Stroke.2003;34(10):2475-2481.
43. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA.1997;277(19) :1539-1545.
44. National Diabetes Surveillance System. Annual Number (in Thousands) of New Cases of Diagnosed Diabetes Among Adults Aged 18-79 Years, United States, 1997-2004.Centers for Disease Control and Prevention; Atlanta, Georgia: 2006.
45. The Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care.2003;26(1):36-47.
46. Hudis CA, Barlow WE, Costantino JP, et al. Endpoints defined: a proposal for standardized definitions for efficacy endpoints in adjuvant breast cancer clinical treatment trials. J Clin Oncol.2007;2127-2132.
47. Sobin L, Wittekind C. TNM Classification of Malignant Tumors.6th ed. New York, NY: Wiley-Liss; 2002.
48. Blackburg GL, Wang KA. Dietary fat reduction and breast cancer outcome: results from the Women's Intervention Nutrition Study (WINS). Am J Clin Nutr.2007;86(3):s878-s881.
49. Freedman AN, Graubard BI, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer prevention. J Natl Cancer Inst.2003;95(7):526-532.
50. Fox CS, Pencina MJ, Meigs JB, Vasan RS, Levitzky YS, D'Agostino RBS. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation.2006;113(25): 2914-2918.
51. Djuric Z, DiLaura NM, Jenkins I, et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res.2002;10(7):657-665.
52. Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA.2006;295(23):2727-2741.
53. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst.1989;81(24):1879-1886.
54. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat.2005;94(2): 115-122.
55. Perry CL, Baranowski T, Parcel GS. How individuals, environments, and health behavior interact: social learning theory. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior & Health Education: Theory Research and Practice.San Francisco, CA: Jossey-Bass; 1990:161-186.
56. Rimer BK. Perspectives on interpersonal theories in health education and health behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Educational Theory Research and Practice.San Francisco, CA: Jossey-Bass; 1990:4140-4157.
57. Dunn A, Marcus B, Kampert J, Garcia M, Kohl HW 3rd, Blair S. Comparison of lifestyle and structured interventions to increase physical activity and cardiorespiratory fitness: a randomized trial. JAMA.1999;281(4):327-334.
58. Writing Group for the Activity Counseling Trial Research Group. Effects of physical activity counseling in primary care. JAMA.2001;286(6):677- 687.
59. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity. Arch Intern Med.2001;161(2):218-227.
60. Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res.2004;12:151S-162S.
61. Hays J, Hunt J R, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol.2003;13:S18-S77.
62. Rubin RR, Fujimoto WY, Marrero DG, et al. The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials.2002;23(1): 157-171.
63. de Castro JM. Dietary energy density is associated with increased intake in free-living humans. J Nutr.2004;134(2):335-341.
64. Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA.2007;298(3):289-298.
65. The Diabetes Prevention Program Research Group. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res.2004;12(9):1426-1434.
66. The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program: description of lifestyle intervention. Diabetes Care.2002;25(12):2165-2171.
67. Demark-Wahnefried W, Clipp EC, Morey MC, et al. Lifestyle intervention development study to improve physical function in older adults with cancer: outcomes from Project LEAD. J Clin Oncol.2006;24(21):3465-3473.
68. Stull VB, Snyder DC, Demark-Wahnefried W. Lifestyle interventions in cancer survivors: designing programs that meet the needs of this vulnerable and growing population. J Nutr.2007;137(1 suppl):243S-248S.
69. The LIFE Study Investigators. Effects of the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P Study). J Gerontol A Biol Sci Med Sci.2006;61A:1157-1165.
70. Rolls BJ. The role of energy density in the overconsumption of fat. J Nutr.2000;130:268S-271S.
71. Bootsmiller BJ, Ribisl KM, Mowbray CT, Davidson WS, Walton MA, Herman SE. Methods of ensuring high follow-up rates: lessons from a longitudinal study of dual diagnosed participants. Subst Use Misuse.1998;33(13):2665-2685.
72. Connolly NB, Schneider D, Hill AM. Improving enrollment in cancer clinical trials. Oncol Nurs Forum.2004;31(3):610-614.
73. Hellard ME, Sinclair MI, Forbes AB, et al. Methods used to maintain a high level of participant involvement in a clinical trial. J Epidemiol Community Health.2001;55(5):249-251.
74. Woolard RH, Carty K, Wirtz P. Research fundamentals: follow-up of subjects in clinical trails: addressing subject attrition. Acad Emerg Med.2004;11(8):859-866.
75. Loftin WA, Barnett SK, Bunn PS, Sullivan P. Recruitment and retention of rural African Americans in diabetes research: lessons learned. Diabetes Educ.2005;31(2):251-268.
76. Laken MP, Ager J. Using incentives to increase participation in prenatal care. Obstet Gynecol.1995;85(3):326-329.
77. Jones R, Zhou M, Yates WR. Improving return rates for health-care outcomes. Psychol Rep.2000;87(2):639-642.
78. Edwards P, Roberts I, Clarke M. Increasing response rates to postal questionnaires: Effect of incentives on response rates must be considered. BMJ.2002;324(7361):1183-1192.
79. Freedman L, Anderson G, Kipnis V, et al. Approaches to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative. Control Clin Trials.1996;17:509-525.
80. ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet.2005;365(9453):60-62.
81. Pierce JP, Newman VA, Flatt SW, et al. Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J Nutr.2004;134(2):452-458.